Gene · 6595
Papers3,459
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
881 to 900 of 3,459
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| EZH2 depletion potentiates MYC degradation inhibiting neuroblastoma and small cell carcinoma tumor formation. | Nat Commun | 2022 | 35013218 | PubTator, text mining | PubMed |
| Temporal Quantitative Phosphoproteomics Profiling of Interleukin-33 Signaling Network Reveals Unique Modulators of Monocyte Activation. | Cells | 2022 | 35011700 | PubTator, text mining | PubMed |
| SNF5, a core subunit of SWI/SNF complex, regulates melanoma cancer cell growth, metastasis, and immune escape in response to matrix stiffness. | Transl Oncol | 2022 | 34999540 | PubTator, text mining | PubMed |
| Precursors and outcomes of work engagement among nursing professionals-a cross-sectional study. | BMC Health Serv Res | 2022 | 34983510 | PubTator, text mining | PubMed |
| The SWI/SNF chromatin remodeling assemblies BAF and PBAF differentially regulate cell cycle exit and cellular invasion in vivo. | PLoS Genet | 2022 | 34982771 | PubTator, text mining | PubMed |
| Clinicopathologic and Genetic Features of Primary T-cell Lymphomas of the Central Nervous System: An Analysis of 11 Cases Using Targeted Gene Sequencing. | Am J Surg Pathol | 2022 | 34980830 | PubTator, text mining | PubMed |
Switch/sucrose-non-fermentable (SWI/SNF) complex (SMARCA4, SMARCA2, INI1/SMARCB1)-deficient colorectal carcinomas are strongly associated with microsatellite instability: an incidence study in 4508 colorectal carcinomas. | Histopathology | 2022 | 34951482 | PubTator, text mining | PubMed |
| Molecular features of primary hepatic undifferentiated carcinoma. | Mod Pathol | 2022 | 34949765 | PubTator, text mining | PubMed |
| Prenatal presentation of multiple anomalies associated with haploinsufficiency for ARID1A. | Eur J Med Genet | 2022 | 34942405 | PubTator, text mining | PubMed |
| Targeting SWI/SNF ATPases in enhancer-addicted prostate cancer. | Nature | 2022 | 34937944 | PubTator, text mining | PubMed |
| Understanding the significance of biological clock and its impact on cancer incidence. | Cancer Lett | 2022 | 34906624 | PubTator, text mining | PubMed |
| Retrospective analysis of a clinical exome sequencing cohort reveals the mutational spectrum and identifies candidate disease-associated loci for BAFopathies. | Genet Med | 2022 | 34906496 | PubTator, text mining | PubMed |
| Sequencing of a Chinese tetralogy of Fallot cohort reveals clustering mutations in myogenic heart progenitors. | JCI Insight | 2022 | 34905512 | PubTator, text mining | PubMed |
| Genomic and transcriptomic profiling reveals distinct molecular subsets associated with outcomes in mantle cell lymphoma. | J Clin Invest | 2022 | 34882582 | PubTator, text mining | PubMed |
| SMARCA4/BRG1-Deficient Sinonasal Carcinoma. | Arch Pathol Lab Med | 2022 | 34871352 | PubTator, text mining | PubMed |
SWI/SNF Complex-deficient Undifferentiated Carcinoma of the Gastrointestinal Tract: Clinicopathologic Study of 30 Cases With an Emphasis on Variable Morphology, Immune Features, and the Prognostic Significance of Different SMARCA4 and SMARCA2 Subunit Deficiencies. | Am J Surg Pathol | 2022 | 34812766 | PubTator, text mining | PubMed |
| Exquisite Sensitivity to Dual BRG1/BRM ATPase Inhibitors Reveals Broad SWI/SNF Dependencies in Acute Myeloid Leukemia. | Mol Cancer Res | 2022 | 34799403 | PubTator, text mining | PubMed |
| Organoid Sensitivity Correlates with Therapeutic Response in Patients with Pancreatic Cancer. | Clin Cancer Res | 2022 | 34789479 | PubTator, text mining | PubMed |
| TTF1-positive SMARCA4/BRG1 deficient lung adenocarcinoma. | J Pathol Transl Med | 2022 | 34775734 | PubTator, text mining | PubMed |
| Advances in integrative African genomics. | Trends Genet | 2022 | 34740451 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6595/papers?page=45